Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Patients Factors & Impacts

Myeloma Facts

What is your experience with Dupixent in your practice?

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Hear from an expert on Identifying Patients who are appropriate candidates for Biologic treatment

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

There is significant unmet need in the management of PN¹